Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose oral imatinib for pulmonary involvement in systemic sclerosis
2007-005322-68Phase 2Active
- Sponsor
- Azienda Ospedaliero-Universitaria delle Marche
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imatinib in systemic sclerosis (SSc) and interstitial lung disease (ILD), sponsored by Azienda Ospedaliero-Universitaria delle Marche. Started Oct 2007; status: active.
02
Drugs
03
Conditions
systemic sclerosis (SSc)interstitial lung disease (ILD)
Beyond the preview
Go deeper on 2007-005322-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005322-68.